| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 754,5 k € | +192.5% | 258,0 k € | -60.9% | 659,7 k € | -13.5% | 762,4 k € | +1159.0% | 60,6 k € | |
| EBITDA | 22,0 k € | +110.8% | -202,7 k € | +21.3% | -257,7 k € | -571.2% | 54,7 k € | +114.8% | -370,6 k € | |
| Operating profit | 18,4 k € | +108.9% | -206,0 k € | +21.2% | -261,4 k € | -596.8% | 52,6 k € | +114.2% | -371,3 k € | |
| Profit/loss | 40,7 k € | +121.0% | -193,7 k € | +24.0% | -254,9 k € | -575.4% | 53,6 k € | +114.5% | -368,6 k € | |
| Equity | -712,9 k € | +5.4% | -753,6 k € | -34.6% | -559,8 k € | -83.6% | -304,9 k € | +15.0% | -358,6 k € | |
| Total assets | 302,0 k € | +31.4% | 229,9 k € | -73.1% | 854,9 k € | -9.8% | 948,1 k € | +403.7% | 188,2 k € | |
| Cash | 287,3 k € | +43.7% | 199,9 k € | -70.9% | 685,9 k € | +1367.8% | 46,7 k € | +340.9% | 10,6 k € | |
| Debts | 1,0 M € | +3.2% | 983,5 k € | -30.5% | 1,4 M € | +12.9% | 1,3 M € | +129.2% | 546,8 k € | |
| Staff | — | — | 4,1 | — | — | |||||
Private limited company · Saint-Josse-ten-Noode · incorporated on 04/03/2021
Private limited company with a balanced profile. Cash position rising (+43.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Precision for Medicine (BEL) is a Private limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Saint-Josse-ten-Noode.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette